KATHLEENA COHEN: Open Payments
NPI 1609532548 · WESTAMPTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 49 payments from 13 companies in 2025. Trend: 2023 $40 · 2024 $155 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 18 | $344 |
| Antares Pharma, Inc. | 4 | $84 |
| Collegium Pharmaceutical, Inc. | 5 | $77 |
| TOLMAR, INC. | 4 | $65 |
| Novo Nordisk Inc | 4 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Astellas Pharma US Inc | 3 | $51 |
| Lilly USA, LLC | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| Averitas Pharma Inc. | 1 | $18 |
Products named: Korlym, XYOSTED, JATENZO, RELISTOR, Veozah, Wegovy, Belbuca, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
